ED1000
The ED1000 should be operated by a trained personnel. This could be an urologist or a nurse under the supervision of an urologist. All users should undergo training by Medispec or its local authorized representative to operate the ED1000.
Shockwaves are healing waves, similar to ultra-sound waves that are generated by an underwater high-voltage spark. Shockwaves are single pulse waves with high-pressure amplitude, small pulse width and a short rise time. Shockwaves are delivered non-invasively, focused by a special ellipsoid reflector.
Patients are eligible for treatment if they have documented vascular related ED and not hormonal, neurological, or psychological pathology.
Patients with the following conditions:
- Any cause of ED other than vascular etiology
- Patients with penile tumor
- Patients with prostatic tumor
- Patients with testicular tumor
- Patients with local tumor at the treatment area
- Patients with skin wound at the treatment area
- Patients with infection at the treatment area
The Urological clinics are by nature discrete. During the treatment, only the treatment administrator is present. Typically, treatment is administered in a private room.
Shockwave therapy is a non-invasive therapy that triggers natural mechanisms in the body, addressing vascular problems that cause Erectile Dysfunction, not merely treating the symptoms.
In other therapies, the treatment can involve either pharmaceutical therapy using PDE5-I (that have systematic load on different organs and can be accompanied with different reported side effects) – or vacuum pumps – to induce a mechanical erection.
Other treatment options offer temporary relief, treating the symptom of ED but not the root cause.
Although there is no doubt on the impact that PDE-5 inhibition medication has on the field of sexual medicine, there is a growing realization that pharmacotherapy is insufficient, especially in the delicate and complex matter of male sexuality. We have to attribute physiological as well as emotional factors that concern the treatments of ED which have not been solved by PDE-5 inhibitors, such as spontaneity in sexual intercourse and self-esteem that is damaged by the dependency on medication in order to be able to have intercourse. The ED1000 is able to address these issues and also treat the cause of the problem, not just manage the symptoms.
The patient sometimes feels a tickling sensation in the treatment area during treatment. This effect passes immediate or shortly after the treatment is stopped.
There is no restriction of sexual activity before or after treatments.
Some of the patients have reported an improvement after 6 treatments already (3 weeks from initiation of therapy).
There is clinical evidence that treatment effect is lasting from 6 months and up to 18 months.
ED1000
The ED1000 should be operated by a trained personnel. This could be an urologist or a nurse under the supervision of an urologist. All users should undergo training by Medispec or its local authorized representative to operate the ED1000.
Shockwaves are healing waves, similar to ultra-sound waves that are generated by an underwater high-voltage spark. Shockwaves are single pulse waves with high-pressure amplitude, small pulse width and a short rise time. Shockwaves are delivered non-invasively, focused by a special ellipsoid reflector.
Patients are eligible for treatment if they have documented vascular related ED and not hormonal, neurological, or psychological pathology.
Patients with the following conditions:
- Any cause of ED other than vascular etiology
- Patients with penile tumor
- Patients with prostatic tumor
- Patients with testicular tumor
- Patients with local tumor at the treatment area
- Patients with skin wound at the treatment area
- Patients with infection at the treatment area
The Urological clinics are by nature discrete. During the treatment, only the treatment administrator is present. Typically, treatment is administered in a private room.
Shockwave therapy is a non-invasive therapy that triggers natural mechanisms in the body, addressing vascular problems that cause Erectile Dysfunction, not merely treating the symptoms.
In other therapies, the treatment can involve either pharmaceutical therapy using PDE5-I (that have systematic load on different organs and can be accompanied with different reported side effects) – or vacuum pumps – to induce a mechanical erection.
Other treatment options offer temporary relief, treating the symptom of ED but not the root cause.
Although there is no doubt on the impact that PDE-5 inhibition medication has on the field of sexual medicine, there is a growing realization that pharmacotherapy is insufficient, especially in the delicate and complex matter of male sexuality. We have to attribute physiological as well as emotional factors that concern the treatments of ED which have not been solved by PDE-5 inhibitors, such as spontaneity in sexual intercourse and self-esteem that is damaged by the dependency on medication in order to be able to have intercourse. The ED1000 is able to address these issues and also treat the cause of the problem, not just manage the symptoms.
The patient sometimes feels a tickling sensation in the treatment area during treatment. This effect passes immediate or shortly after the treatment is stopped.
There is no restriction of sexual activity before or after treatments.
Some of the patients have reported an improvement after 6 treatments already (3 weeks from initiation of therapy).
There is clinical evidence that treatment effect is lasting from 6 months and up to 18 months.
CARDIOspec
The Cardiospec should be used by an echocardiography specialist. This could be a cardiologist or an echo technician supervised by the cardiologist who determined the course of treatment. All users should undergo training by Medispec or its local authorized representative to operate the Cardiospec.
Patients with documented myocardial ischemia not eligible for “conventional” treatment such as PCI or CABG or has Refractory Angina (Incomplete revascularization, CABG/PTCA failure, Disease progression in native coronary arteries, inadequate treatment of concomitant diseases (e.g., hypertension), Microvascular dysfunction). Patient should have angina or angina equivalent symptoms prior to therapy. Therapy had higher success rate the higher the angina grade.
Patients with the following conditions (selected list):
- Patients with intracardiac Thrombus
- Patients with malignancy at the area of treatment
- Pulmonary disease (emphysema) that blocks the acoustic window
- Pregnancy
No. Although no side effects were reported so far, patients at high risk (poor hemodynamic conditions) are recommended to stay in the hospital for monitoring following the treatment.
No. Unlike Urologic applications, Cardiac shock wave therapy requires less powerful shock waves (1/10th of Lithotripsy). For that reason, the CardiospecTM is fitted with a smaller generator, producing less intense electrical sparks thus generating significantly less noise. There is no need to wear ear protection during treatment.
No. There were no reports of side effects during, immediately after or post treatment.
There was no pain associated and no signs of local hemorrhage. Vital parameters, cardiac enzymes and ECG were unchanged. In addition, there was no indication of arrhythmias and new wall motion abnormalities.
Yes. Shock waves could be delivered as long as there is a clinical need for collaterals development.
No, but if needed, it is recommended to monitor cardiac enzymes and controlled ECG. All showed negative in the studies performed.
Yes. There is a reduction of at least 85% in the weekly intake of nitrates after treatment.